In addition to TNF signaling, the involvement of both the IL-1 and TLR pathways are well established in IBD pathology [85-88]; in the colonic mucosa, TNF, IL1A, and Toll-like receptor signaling all activate NF κB leading to further expression of inflammatory mediator genes [89]. Here, IL1A is linked to inflammatory bowel disease.